NLRP3: A promising therapeutic target for autoimmune diseases.
Autoimmun Rev. 2018 Jul;17(7):694-702. doi: 10.1016/j.autrev.2018.01.020. Epub 2018 May 3.
Autoimmun Rev. 2018.
PMID: 29729449
Review.